Industry Reps Call for 4-6 Year Extension of Trial for Premium for New Drug Development

December 15, 2011
Top officials of foreign and domestic pharmaceutical industry organizations including the Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) presented their views on next year’s reform of the NHI drug price system at a meeting of the Central Social Insurance...read more